MRNA
Moderna Inc
NASDAQ: MRNA · HEALTHCARE · BIOTECHNOLOGY
$45.72
-3.01% today
Updated 2026-04-29
Market cap
$18.13B
P/E ratio
—
P/S ratio
9.33x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $60
Volume
7.5M
Moderna Inc (MRNA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $9.22M | $261848.00 | $1.42B | $1.08B | $1.96B | $1.59B | $7.34B | $24.67B | $25.86B | $18.43B | $14.14B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $2.52M | $261848.00 | $1.09B | $783.22M | $1.56B | $1.13B | $6.30B | $16.07B | $13.43B | $10.32B | $8.10B |
| Total liabilities | $13.59M | $171663.00 | $575.31M | $459.19M | $431.91M | $414.61M | $4.78B | $10.52B | $6.74B | $4.57B | $3.24B |
| Current liabilities | $1.94M | $135193.00 | $162.80M | $191.46M | $222.80M | $143.12M | $4.39B | $9.13B | $4.92B | $3.02B | $2.21B |
| Long-term debt | — | — | $12.50M | $15.69M | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-337.79M | $-1.11M | $-365.72M | $-621.89M | $-1.01B | $-1.50B | $-2.24B | $9.96B | $18.32B | $13.61B | $10.04B |
| Accounts receivable | $500000.00 | — | $17.95M | $16.66M | $30.58M | $16.30M | $1.41B | $3.32B | $1.69B | $1.08B | $592.00M |
| Inventory | — | — | — | — | $-172.99M | $-904.19M | $47.00M | $1.44B | $949.00M | $202.00M | $117.00M |
| Goodwill | — | — | $3.56M | $3.50M | — | — | — | — | $0.00 | $52.00M | $52.00M |